Zimmer Biomet
982 hedge funds and large institutions have $19.5B invested in Zimmer Biomet in 2024 Q3 according to their latest regulatory filings, with 83 funds opening new positions, 296 increasing their positions, 405 reducing their positions, and 95 closing their positions.
3% less capital invested
Capital invested by funds: $20.2B → $19.5B (-$671M)
1.51% less ownership
Funds ownership: 90.46% → 88.95% (-1.5%)
2% less funds holding
Funds holding: 1,006 → 982 (-24)
13% less first-time investments, than exits
New positions opened: 83 | Existing positions closed: 95
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
27% less repeat investments, than reductions
Existing positions increased: 296 | Existing positions reduced: 405
64% less call options, than puts
Call options by funds: $46.2M | Put options by funds: $127M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$227M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$110M |
| 3 |
EIC
Equity Investment Corp
Atlanta,
Georgia
|
+$70.9M |
| 4 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$63M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$62.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$146M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$125M |
| 3 |
Goldman Sachs
New York
|
-$89.5M |
| 4 |
JP Morgan Chase
New York
|
-$89.4M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
-$75.5M |
ZBH Hedge Fund Activity: Q3 2024 in Review
982 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q3 2024, worth a combined $19.5B — down 3.3% from $20.2B a quarter earlier.
Sellers outnumbered buyers: 95 funds closed out of ZBH and 83 opened new positions — a net loss of 12 holders — while 405 trimmed existing stakes and 296 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $227M. The largest seller was Invesco, cutting an estimated $146M.
- 982 institutional investors held Zimmer Biomet (ZBH) as of Q3 2024, down from 1,006 in Q2 2024.
- Funds reported $19.5B of Zimmer Biomet stock for Q3 2024, down 3.3% quarter-over-quarter.
- 83 funds opened new Zimmer Biomet positions in Q3 2024 and 95 closed out, a net change of -12 holders.
- The largest Zimmer Biomet buyer in Q3 2024 was T. Rowe Price Associates, an estimated $227M added.
- The largest Zimmer Biomet seller in Q3 2024 was Invesco, an estimated $146M sold.
Based on aggregated 13F filings for Q3 2024.